Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
Nathan Hambly, M Malik Farooqi, Anna Dvorkin-Gheva...
https://pubmed.ncbi.nlm.nih.gov/35273032/Actively Recruiting
Led by Istituto Clinico Humanitas · Updated on 2026-08-27
156
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating a new type of CT scan called photon-counting detector CT PCDCT compared to the standard high-resolution CT HRCT scan to better identify idiopathic pulmonary fibrosis IPF and other interstitial lung diseases ILD. The study aims to improve diagnostic confidence, reduce cases where ILD cannot be clearly classified, and assist in multidisciplinary diagnosis discussions. This observational study is sponsored by Istituto Clinico Humanitas. Participants will undergo non-contrast enhanced chest CT scans using the PCDCT system, which offers advanced features like higher image resolution and lower radiation dose. These scans are performed in a spectral ultra-high-resolution mode with automated exposure control. The PCDCT images are compared to standard HRCT images to see if they provide clearer details of lung abnormalities related to ILD, potentially leading to more accurate diagnosis. During the study, participants will have their scans reviewed in multidisciplinary discussions to determine the ILD diagnosis. Researchers will measure how often unclassifiable ILD cases are reduced and how frequently IPF diagnoses increase when using PCDCT versus standard HRCT. The agreement between radiologists interpreting the scans will also be assessed. The study will follow participants for up to two years to observe these outcomes.
CONDITIONS
Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis
F
Francesco Amati, MD
L
Lisa Usuelli, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Istituto Clinico Humanitas
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 years
Participants will have chest CT scans using both photon-counting detector CT and standard high-resolution CT. The images will be reviewed in multidisciplinary discussions to assist in diagnosis.
Visits as needed for imaging and discussions
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Nathan Hambly, M Malik Farooqi, Anna Dvorkin-Gheva...
https://pubmed.ncbi.nlm.nih.gov/35273032/Florian Prayer, Patric Kienast, Andreas Strassl...
https://pubmed.ncbi.nlm.nih.gov/36445225/Kishore Rajendran, Chi Wan Koo
https://pubmed.ncbi.nlm.nih.gov/37071170/David A Lynch, Nicola Sverzellati, William D Travis...
https://pubmed.ncbi.nlm.nih.gov/29154106/Ganesh Raghu, Martine Remy-Jardin, Luca Richeldi...
https://pubmed.ncbi.nlm.nih.gov/35486072/Sabina A Guler, Christopher J Ryerson
https://pubmed.ncbi.nlm.nih.gov/30004990/Christopher J Ryerson, Thomas H Urbania, Luca Richeldi...
https://pubmed.ncbi.nlm.nih.gov/23222877/Istituto Clinico Humanitas
Lead Sponsor